# High-dose Brachytherapy Boost With Stereostatic Body Radiation Therapy to Intermediate or Higher Risk Prostate Cancer

> **NCT05754580** · NA · RECRUITING · sponsor: **University of Nebraska** · enrollment: 53 (estimated)

## Conditions studied

- Prostatic Cancer

## Interventions

- **RADIATION:** High Dose Brachytherapy
- **RADIATION:** Stereostatic Body Radiation Therapy

## Key facts

- **NCT ID:** NCT05754580
- **Lead sponsor:** University of Nebraska
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-08-29
- **Primary completion:** 2026-10
- **Final completion:** 2027-10
- **Target enrollment:** 53 (ESTIMATED)
- **Last updated:** 2025-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05754580

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05754580, "High-dose Brachytherapy Boost With Stereostatic Body Radiation Therapy to Intermediate or Higher Risk Prostate Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05754580. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*